Larimar Therapeutics Inc (LRMR)
EBITDA Growth
-25.39%
Quarterly · Period ending:
LRMR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-25.39%period ending
Latest reported-25.39%period ending
LRMR Quarterly EBITDA YoY % (-194.19% → -25.39%)
Year-over-year change
High-resolution chart · PNG
LRMR ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -25.388% | |
| -1.2195% | |
| -117.1044% | |
| -208.7455% | |
| -21.1467% | |
| -100.3088% | |
| -122.6379% | |
| -71.6177% | |
| -159.8311% | |
| -126.0236% | |
| -38.1406% | |
| -9.038% | |
| 3.4475% | |
| 27.2317% | |
| -3.3274% | |
| 50.6909% | |
| 31.4874% | |
| 26.3608% | |
| 36.9441% | |
| -62.5377% | |
| -10.249% | |
| -80.9202% | |
| -133.7243% | |
| -19.4819% | |
| -208.4668% | |
| -41.3603% | |
| 57.1339% | |
| 41.7788% | |
| 76.3175% | |
| 72.2566% | |
| -2.8147% | |
| -15.148% | |
| -14.9527% | |
| -32.1515% | |
| -35.4635% | |
| 13.4246% | |
| 10.1315% | |
| 26.4036% | |
| 53.6412% | |
| 24.7806% | |
| 14.4691% | |
| -28.6958% | |
| -37.2955% | |
| -194.1864% |